PetLife Announces its All-natural ‘Cancer Cocktail’ With Applicability to Pet and Human Markets

The Company may be the first to offer an all-natural cancer cocktail combining the therapeutic benefits of the plant and animal kingdoms PR Newswire, PTLF HANCOCK, Maryland, June 14, 2017 HANCOCK, Maryland, June 14, 2017 /PRNewswire/ PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the Company ), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, reports on its solution to the ever increasing problem of drug resistance and high toxicity in the treatment of cancer in
http://bit.ly/2sM14xq